title: Development of proteinuria and focal segmental glomerulosclerosis during direct-acting antiviral therapy for hepatitis C virus infection.
authors.affiliation: Division of Nephrology, University of Pennsylvania, Philadelphia, PA.
authors.forename: Jonathan J
authors.initials: JJ
authors.lastname: Hogan
authors.affiliation: Division of Nephrology, University of Pennsylvania, Philadelphia, PA.
authors.forename: Mary Ann
authors.initials: MA
authors.lastname: Lim
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA.
authors.forename: Matthew B
authors.initials: MB
authors.lastname: Palmer
authors.affiliation: Division of Nephrology, University of Pennsylvania, Philadelphia, PA.
authors.forename: Roy D
authors.initials: RD
authors.lastname: Bloom
authors.affiliation: Liver Center, Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
authors.forename: Raymond T
authors.initials: RT
authors.lastname: Chung
authors.affiliation: Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
authors.forename: Meghan E
authors.initials: ME
authors.lastname: Sise
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000139:chemically induced*; D006526:Hepatitis C / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011507:Proteinuria / Q000139:chemically induced*
chemical_list: D000998:Antiviral Agents